Article Data Are Unclear About the Effectiveness of Laquinimod in Multiple Sclerosis—by Stuart Cook, MD Read More
Article Tool Allows MS Patients to Assess How Their Impairment Compares to That of Other Patients With Same Disease Duration Read More
Article Combined Use of Interferon beta-1a and Glatiramer Acetate May Not Be Superior to Glatiramer Acetate Alone in Reducing MS Relapses Read More
Article The CombiRx Trial Could Shed Light on the MS Disease Process—by Richard A. Rudick, MD Read More
Article Alemtuzumab Will Help Clinicians Treat Patients With MS More Effectively—By Mark Gudesblatt, MD Read More
Article Alemtuzumab May Be Superior to Interferon Beta-1a in Patients With MS—Results From the CARE-MS II Study Author: Patients Who Received Alemtuzumab Had Lower Relapse Rates Reduced Disability A Read More
Article Alemtuzumab May Provide Greater Benefit Than Interferon Beta-1a for Treatment-Naïve Patients With MS—Results From the CARE-MS I Study Read More